23 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• Bionano Genomics, Inc. BNGO stock increased by 41.3% to $1.27 during Thursday's pre-market session. The market value of their outstanding shares is at $7.8 million.
• InflaRx, Inc. IFRX shares rose 28.2% to $3.32. The market cap seems to be at $64.1 million.
• DexCom, Inc. DXCM stock moved upwards by 20.2% to $184.00. The market value of their outstanding shares is at $13.9 billion. The most recent rating by UBS, on November 07, is at Neutral, with a price target of $185.00.
• Livongo Health, Inc. LVGO stock increased by 13.2% to $24.00. The market cap stands at $1.8 billion. The most recent rating by Morgan Stanley, on August 28, is at Overweight, with a price target of $42.00.
• TherapeuticsMD, Inc. TXMD shares rose 11.8% to $2.93. The market cap stands at $875.6 million.
• Lexicon Pharmaceuticals, Inc. LXRX shares surged 9.3% to $4.21. The market value of their outstanding shares is at $394.2 million. According to the most recent rating by Gabelli & Co., on September 11, the current rating is at Buy.
• Clovis Oncology, Inc. CLVS shares increased by 7.4% to $3.85. The market value of their outstanding shares is at $233.3 million. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $3.00.
• Cardinal Health, Inc. CAH stock rose 3.7% to $53.30. The market cap seems to be at $13.7 billion. The most recent rating by Deutsche Bank, on September 12, is at Hold, with a price target of $50.00.
• Dentsply Sirona, Inc. XRAY shares rose 3.4% to $57.50. The market cap seems to be at $12.2 billion.
• Canopy Growth, Inc. CGC stock rose 3.2% to $20.05. The market cap seems to be at $11.0 billion. The most recent rating by Piper Jaffray, on October 22, is at Overweight, with a price target of $36.00.
• Coherus BioSciences, Inc. CHRS shares rose 2.7% to $16.90. The market value of their outstanding shares is at $1.5 billion. The most recent rating by Citigroup, on November 07, is at Buy, with a price target of $31.00.

Losers

• EyePoint Pharmaceuticals, Inc. EYPT shares decreased by 24.2% to $1.75 during Thursday's pre-market session. The market value of their outstanding shares is at $203.5 million. The most recent rating by B. Riley, on September 24, is at Buy, with a price target of $4.00.
• Puma Biotechnology, Inc. PBYI shares decreased by 15.8% to $6.00. The market cap seems to be at $470.6 million. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $8.00.
• Agile Therapeutics, Inc. AGRX shares decreased by 11.7% to $2.18. The market value of their outstanding shares is at $70.2 million.
• Bellicum Pharmaceuticals, Inc. BLCM stock plummeted 8.6% to $1.17. The market cap stands at $49.4 million.
• Adamis Pharmaceuticals, Inc. ADMP stock decreased by 8.3% to $0.88. The market value of their outstanding shares is at $49.7 million.
• Quotient, Inc. QTNT stock plummeted 5.7% to $7.25. The market value of their outstanding shares is at $532.9 million.
• Constellation, Inc. CNST stock declined 5.2% to $26.65. The market value of their outstanding shares is at $166.8 million. The most recent rating by RBC Capital, on September 04, is at Outperform, with a price target of $20.00.
• AVEO Pharmaceuticals, Inc. AVEO stock plummeted 3.8% to $0.51. The market cap seems to be at $153.4 million. The most recent rating by H.C. Wainwright, on September 11, is at Buy, with a price target of $1.75.
• Evolus, Inc. EOLS shares declined 3.2% to $13.55. The market value of their outstanding shares is at $437.4 million. The most recent rating by Mizuho, on September 05, is at Buy, with a price target of $30.00.
• Precipio, Inc. PRPO shares declined 3.0% to $2.30. The market cap stands at $15.9 million.
• Guardion Health Sciences, Inc. GHSI stock decreased by 2.8% to $0.27. The market cap stands at $20.3 million.
• Mallinckrodt, Inc. MNK shares declined 2.7% to $2.93. The market cap seems to be at $265.6 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.